Key result
Metabolic syndrome is linked to more carotid plaques and IMT > 0.80 mm in asymptomatic participants.
Why the study?
Is metabolic syndrome associated with increased carotid intima-media thickness and carotid plaques in asymptomatic individuals?
Cross-Sectional (n=479)
Is metabolic syndrome associated with increased carotid intima-media thickness and carotid plaques in asymptomatic individuals?
Metabolic syndrome is significantly associated with early markers of carotid atherosclerosis, including increased intima-media thickness and plaques, in asymptomatic individuals.
Answers are grounded in this paper and cite their sources.
May signal higher subclinical carotid atherosclerosis risk with metabolic syndrome; leaves open need for longitudinal outcome confirmation.
The metabolic syndrome (MetS) has previously been associated with an early marker of atherosclerosis, the carotid intima-media thickness (IMT). From the ISMIR (Ispessimento Medio Intimale e Rischio cardiovascolare [media-intima thickness and cardiovascular risk]) study population of 479 asymptomatic participants, we identified 80 participants with MetS. Carotid IMT and plaques were evaluated by ultrasonography. Blood samples were obtained from all participants. Participants with MetS had a significantly higher prevalence of a carotid IMT > 0.80 mm (P = .004) and of carotid plaques (P < .001) as compared with participants without MetS. Carotid IMT was significantly correlated with fasting triglycerides and fibrinogen levels both in participants with MetS and in those without MetS (all P < .01). In contrast, IMT correlated with fasting plasma glucose, serum creatinine, and uric acid levels only in participants without MetS. Our study confirms the association between MetS and carotid atherosclerosis. In MetS, a significant correlation between carotid IMT and triglycerides and fibrinogen levels was found.
No takes yet. Share an insight, caveat, or question.
Antonini‐Canterin et al. (2010) conducted a cross-sectional in Metabolic syndrome (n=479). Metabolic syndrome vs. Participants without metabolic syndrome was evaluated on Prevalence of carotid IMT > 0.80 mm and carotid plaques (p=0.004 for IMT > 0.80 mm; <0.001 for plaques). Metabolic syndrome was associated with a higher prevalence of carotid IMT > 0.80 mm and carotid plaques in asymptomatic participants.
Synapse has enriched 10 related papers. Consider them for comparative context: